about
High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adductsPolycyclic aromatic hydrocarbon biomarkers of internal exposure in US Army soldiers serving in Kuwait in 1991SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.STrengthening the Reporting of OBservational studies in Epidemiology: Molecular Epidemiology STROBE-ME. An extension of the STROBE statement.STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement.Environmental, dietary, maternal, and fetal predictors of bulky DNA adducts in cord blood: a European mother-child study (NewGeneris)Development and validation of a direct sandwich chemiluminescence immunoassay for measuring DNA adducts of benzo[a]pyrene and other polycyclic aromatic hydrocarbonsCorrelation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.Bulky dna adducts in cord blood, maternal fruit-and-vegetable consumption, and birth weight in a European mother-child study (NewGeneris).Validation of biomarkers for the study of environmental carcinogens: a review.Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: the NewGeneris cohortSmoking-related O4-ethylthymidine formation in human lung tissue and comparisons with bulky DNA adducts.Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis.Erratum: "Environmental, Dietary, Maternal, and Fetal Predictors of Bulky DNA Adducts in Cord Blood: A European Mother-Child Study (NewGeneris)".Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study.Highly sensitive chemiluminescence immunoassay for benzo[a]pyrene-DNA adducts: validation by comparison with other methods, and use in human biomonitoring.CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls.Association of metabolic gene polymorphisms with tobacco consumption in healthy controls.CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene-gene interactions.Glutathione S-transferase enzyme polymorphisms in a Hungarian myelodysplasia study population.DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary.Corrigendum to “STrengthening the Reporting of OBservational studies in Epidemiology — Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement” [Prev. Med. 53 (2011) 377–387]Erratum to: STrengthening the reporting of OBservational studies in Epidemiology—Molecular Epidemiology (STROBE-ME): an extension of the STROBE statementSTrengthening the Reporting of OBservational studies in Epidemiology — Molecular Epidemiology STROBE-ME: an extension of the STROBE statement [J Clin Epidemiol 2011;64(12):1350–1363]STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statementSTrengthening the Reporting of OBservational studies in Epidemiology — Molecular Epidemiology (STROBE-ME): An extension of the STROBE statementSTrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology STROBE-ME: an extension of the STROBE statementSTrengthening the reporting of OBservational studies in Epidemiology—Molecular Epidemiology (STROBE-ME): an extension of the STROBE statementHelp needed for Eastern EuropeBiomarkers and molecular epidemiology--present state and future trends: concluding remarks[The role of DNA adducts in smoking-related carcinogenesis]
P50
Q23912890-3A9BEBDF-273F-4300-852D-B4A8E4D9F9BBQ23918489-7354CC57-AF00-4311-9E48-104008F6B000Q33710175-A008E22D-801F-49D9-95E8-43502E6E8C96Q34057012-97B2DF4E-790A-4697-B3CD-F05B395FDF62Q34062156-36E7A210-CE86-4865-93A9-85C71607426EQ35250873-60DB0F68-02B2-488B-9348-1A739266ACFCQ36175114-ADA673E5-65F5-4501-B577-ADA9C42EB908Q36995827-EFECB33E-C79E-434E-85E7-D4F792E0F637Q37241112-7C98EE49-3B15-43E3-BE64-3B59A965A7FAQ37315784-C23043A8-95DF-4344-91AF-4B62EB3B1CADQ37558210-777105A3-D3A3-4EAB-BA8A-0A704120068EQ38411077-F1D00AC3-764F-4E62-9B61-08561325BC77Q39607573-728B5DE5-92CE-4CFC-991C-1A4054F4BE8FQ39650461-F24D4EA5-E277-4F6E-B599-517B3FFAA5D0Q43091847-67C4104C-29DB-47E1-9D51-EAE68C194A1FQ44218297-65489C80-C7DC-4FE5-9F7F-3A6A6A750558Q44266875-262050BF-C998-48C6-8C59-F165BCBCC1B2Q44321042-FE11CF7E-B755-4ADF-AB93-8754010FCDB5Q44834254-40B8EE5E-9CE1-4469-853D-BA607347A8C0Q46374969-EB772EE7-25A3-49CC-AF5F-A08E6871691DQ46584342-B147E773-FF43-4432-9B10-5A0B725CFD4FQ50768216-83B4B29D-86C3-4946-8C81-65DCE9CF79B6Q50782220-DA2203C3-6FE3-43FB-9E24-D25349E0F2DEQ56525039-2B5F6127-F826-4D14-B5FE-CA1A9E20DFFCQ56525153-1CAAFD0B-09AE-4392-BA09-37C827286FABQ56525200-EB2D0B8F-133C-4019-8A16-EACB9FDEBC1DQ56525359-BAF6B24E-E1F5-4007-B217-6FB975F9AABBQ56525808-C3377933-0C23-4E9C-A68E-69DE0DECCBA0Q56525816-7EDD885B-716A-4CA5-81D7-19205ED4F71BQ56525829-0992ABDE-A592-41F4-853E-F62D21914BCFQ60063973-8390956C-E60B-4D98-B744-379DF8A0DEB6Q79808470-607FAAE3-B1F5-4883-A9D7-0B8BC97DB5E0Q80947301-B7420068-45D6-42A1-B8A2-18E0C5AF4B59
P50
name
Bernadette Schoket
@en
type
label
Bernadette Schoket
@en
prefLabel
Bernadette Schoket
@en